New Haven, Connecticut 06520

  • Anxiety

Purpose:

This is a randomized controlled trial of Cognitive Behavioral Therapy (CBT) versus Psychoeducation and Supportive Therapy (PST) in children with Autism Spectrum Disorder and moderate to severe anxiety. The study will utilize fMRI to identify CBT-invoked changes in levels of activity/functional connectivity within the neural circuits involved in emotion regulation and social perception. Matched typically developing children without autism and/or anxiety will be scanned twice, 16 weeks apart, to enable interpretation of treatment-evoked change relative to normative development.


Study summary:

Anxiety is among the most common concerns in children with autism spectrum disorder (ASD) who seek mental health services, causing suffering and family stress and exacerbating social disability. Cognitive-Behavioral Therapy (CBT) is a promising treatment for anxiety in children with high-functioning ASD, but the neural mechanisms supporting response to this treatment have not been studied. The neural-systems-level targets of CBT for anxiety in children with ASD will be investigated by evaluating brain indices of socio-emotional functioning with functional magnetic resonance imaging (fMRI) before and after treatment. CBT teaches emotion regulation skills, such as cognitive reappraisal, followed by behavioral exposure to anxiety-provoking situations. It is hypothesized that CBT aimed at the reduction of anxiety will enhance the neural circuitry that subserves the experience and regulation of emotions. This is a randomized controlled trial of CBT vs. Psychoeducation and Supportive Therapy (PST) in 100 school-age children with high-functioning ASD and moderate to severe anxiety. In addition, 50 matched typically-developing (TD) children will be scanned twice with a 16-week interval to enable interpretation of change in brain function in children with ASD after CBT vs. PST relative to TD children. CBT for anxiety will be provided using a structured manual that has been modified for children with ASD by increasing parental participation and addressing the role of core ASD symptoms in the experience and expression of anxiety. Subjects will be comprehensively characterized with regard to ASD diagnosis, IQ, adaptive behavior, and comorbid psychopathology. Functional MRI will be collected as the subjects perform tasks involving emotion regulation, emotional face perception, biological motion perception, and resting state.


Criteria:

Inclusion Criteria: - Boys and girls, ages 8 to 14 inclusive - Diagnosis of autism spectrum disorder - Diagnosis of anxiety disorder and clinically significant level of anxiety - Full scale IQ and Verbal IQ > 70 - Unmedicated or on stable medication with no planned changes for duration of study - able to meet MRI safety (e.g., no metal medical implants) and data quality requirements (e.g., able to keep head still during scanning) Exclusion Criteria: - Presence of a known serious medical condition that would interfere with participation in the study - Present of a current psychiatric disorder that requires immediate clinical attention - A previous adequate trial of CBT for anxiety within the past 2 years. Note: This study will also recruit healthy volunteers (typically developing children without past or current mental health concerns).


NCT ID:

NCT02725619


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

New Haven, Connecticut 06520
United States

Denis Sukhodolsky, Ph.D.
Phone: 203-785-6446
Email: denis.sukhodolsky@yale.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: September 16, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.